Supply of medicinal products outside Annex 2 of the Positive Drug List for the needs of the State Psychiatric Hospital - Kardzhali
Originaltitel der Bekanntmachung
Bulgaria – Pharmaceutical products – „Доставка на лекарствени продукти извън Приложение №2 на Позитивния лекарствен списък за нуждите на ДПБ-Кърджали“.
Opportunity Score
Warum diese Bewertung?
Chance
40 / 100
Komplexität
35 / 100
Risikofaktoren
Foreign bidders must obtain Bulgarian licenses or equivalent documents, which may be time-consuming and costly.
Inconsistent EU-funding flags between structured data (yes) and XML notice (no) may affect payment conditions or contra...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Moderate opportunityWichtige Fakten
- BGN 100k estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration until Apr 2028
- Supply of pharmaceutical products outside Annex 2 of the Positive Drug List
- Deliveries to the State Psychiatric Hospital in Kardzhali, Bulgaria
Vollständige Zusammenfassung anzeigen
Bulgaria – Pharmaceutical products – Supply of medicinal products outside Annex 2 of the Positive Drug List for the needs of the State Psychiatric Hospital - Kardzhali. Dynamic Purchasing System (DPS), single lot, estimated value 100,000 BGN, restricted procedure, duration 3 years (2025-2028).
Risiken
Foreign bidders must obtain Bulgarian licenses or equivalent documents, which may be time-consuming and costly.
Inconsistent EU-funding flags between structured data (yes) and XML notice (no) may affect payment conditions or contra...
Restricted procedure — pre-qualification required
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Valid authorization for production, wholesale, or import of medicinal products under Bulgarian Medicinal Products Act
Certifications
- For narcotics (items 32-33): valid license under Bulgarian Narcotic Substances Control Act
Administrative
- Electronic submission via CAIS EOP platform
Anforderungen können unvollständig sein.
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
гр.Кърджали, BGR
Website
Auftraggeberprofil
Kennung
000234067
Tätigkeit
Health
Lose (1)
LOT-0001
Supply of medicinal products outside Annex 2 of the Positive Drug List for the needs of the State Psychiatric Hospital - Kardzhali
Supply of pharmaceutical products not covered by Annex 2 of the Positive Drug List to the State Psychiatric Hospital in Kardzhali, Bulgaria. DPS, single lot.
BGN 100k
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
НАЙ - НИСКА ЦЕНА
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
„Доставка на лекарствени продукти извън Приложение №2 на Позитивния лекарствен списък за нуждите на ДПБ-Кърджали“.
Originale TED-Beschreibung
Целта на обществената поръчка е да се удовлетвори нуждите на ДПБ - Кърджали от доставки на лекарствени продукти извън Приложение №2 на Позитивния лекарствен списък.
Vergabedetails
- Veröffentlichungsdatum
- 27 Apr 2025
- Sprachen
- Bulgarian
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 272594-2025
Dokumente (1)
Ähnliche Ausschreibungen
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Warum diese Bewertung?
Chance
40 / 100
Komplexität
35 / 100
Risikofaktoren
Foreign bidders must obtain Bulgarian licenses or equivalent documents, which may be time-consuming and costly.
Inconsistent EU-funding flags between structured data (yes) and XML notice (no) may affect payment conditions or contra...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications